The Anti-Inflammatory Compound Lisofylline Prevents Type I Diabetes in Non-Obese Diabetic Mice

Diabetologia - Germany
doi 10.1007/s00125-002-0901-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search